[HTML][HTML] Effectiveness and safety of oxaliplatin compared to cisplatin for advanced, unresectable gastric cancer: a systematic review and meta-analysis

F Montagnani, G Turrisi, C Marinozzi, C Aliberti… - Gastric Cancer, 2011 - Springer
Background Cisplatin has been largely used in the treatment of advanced, unresectable
gastric cancer, mainly in combinations with fluoropyrimidines and anthracyclines. Oxaliplatin …

Intra-arterial hepatic chemoembolization (TACE) of liver metastases from ocular melanoma with slow-release irinotecan-eluting beads. Early results of a phase II …

…, A Del Conte, M Tilli, S Rossi, P Ballardini, G Turrisi… - in vivo, 2009 - iv.iiarjournals.org
Background: Uveal melanoma (UM) is the most common primary intraocular malignancy in
adults and the liver is the predominant site of metastases (LM). If metastases appear, none of …

A phase II clinical study on relapsed malignant gliomas treated with electro-hyperthermia

…, P Giovanis, S Rossi, P Dentico, R Paola, G Turrisi… - in vivo, 2006 - iv.iiarjournals.org
The purpose of this study was to evaluate the activity and toxicity of electro-hyperthermia (ET)
on relapsed malignant glioma patients. Twelve patients with histologically diagnosed …

Intraarterial hepatic chemoembolization of liver metastases from colorectal cancer adopting irinotecan-eluting beads: results of a phase II clinical study

G Fiorentini, C Aliberti, G Turrisi, A Del Conte, S Rossi… - in vivo, 2007 - iv.iiarjournals.org
Since November 2005 a clinical trial of intraarterial hepatic chemoembolization (TACE) with
irinotecan-eluting beads has been ongoing in 20 patients affected by liver metastases from …

Hepatic arterial chemotherapy in combination with systemic chemotherapy compared with hepatic arterial chemotherapy alone for liver metastases from colorectal …

…, P Dentico, A Mambrini, P Bernardeschi, G Turrisi… - in vivo, 2006 - iv.iiarjournals.org
Hepatic arterial infusion (HAI) chemotherapy is accepted to be an option in patients with non-resectable
metastases from colorectal cancer confined to the liver. In a multi-istitutional trial, …

Congestive heart failure during imatinib mesylate treatment

G Turrisi, F Montagnani, S Grotti, C Marinozzi… - International journal of …, 2010 - Elsevier
Imatinib mesylate (IM) is a very important drug in the treatment of gastrointestinal stromal
tumors (GISTs) and chronic myeloid leukaemia (CML). In large clinical trials conducted until …

Bisphosphonate-induced osteonecrosis of the jaw 32 months after interruption of zoledronate in a patient with multiple myeloma

…, P Bernardeschi, F La Ferla, G Turrisi… - Journal of oral and …, 2010 - joms.org
Bisphosphonates prevent, reduce, and delay cancer-related skeletal complications in patients
with multiple myeloma or metastatic cancer. 1 Thus, the therapy is commonly prescribed …

[PDF][PDF] Thyroid metastases from colorectal cancer: no longer a rare entity

G Fiorentini, S Rossi, G Porcu, P Dentico, G Turrisi… - Tumori …, 2006 - academia.edu
We have read with interest the articles by Kensuke Kumamoto et al.'and Franco Mattavelli et
al. 2 We appreciate the efforts of these authors to confirm the importance of the diagnosis of …

Advanced cancer of the ovary: intraperitoneal chemotherapy as a new therapeutical option

G Fiorentini, M Filippeschi, G Turrisi, A Mambrini… - In Vivo, 2009 - iv.iiarjournals.org
Intraperitoneal (IP) chemotherapy has been used in patients presenting different stages of
ovarian cancer. We performed a critical review of the available literature on IP as first-line …

Persistent thrombocytopenia during melanoma treatment with fotemustine

G Turrisi, P Sozzi, C Marinozzi, MA Clerico - Melanoma research, 2006 - journals.lww.com
Haematological toxicity characterized by delayed and reversible neutropenia and/or
thrombocytopenia is an adverse effect observed in 40% of patients receiving fotemustine. We report …